Hedge Fund - Biotechnology Value Fund / BVF Inc

In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.

In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.

Forward Pharma A/S (NASDAQ:FWP): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

Erytech Pharma SA (ADR) (NASDAQ:ERYP): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

Please follow Biotechnology Value Fund LP (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Biotechnology Value Fund LP or update its stock holdings...

Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

Syndax Pharmaceuticals Inc (NASDAQ:SNDX): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

Spero Therapeutics Inc (NASDAQ:SPRO): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.

Arqule Inc (NASDAQ:ARQL): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP's latest holdings and filings here.